Home

Decorativo Sicilia negozio di alimentari ym155 clinical trial paraninfo Rovinare Sembrare

Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium  Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports

Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium  Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports

Changes in survivin expression in serial biopsied tumor pre- and... |  Download Scientific Diagram
Changes in survivin expression in serial biopsied tumor pre- and... | Download Scientific Diagram

Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a  Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines

Testing of the survivin suppressant YM155 in a large panel of drug-resistant  neuroblastoma cell lines | bioRxiv
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv

YM155 and BIRC5 downregulation induce genomic instability via  autophagy-mediated ROS production and inhibition in DNA repair -  ScienceDirect
YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair - ScienceDirect

Testing of the survivin suppressant YM155 in a large panel of drug-resistant  neuroblastoma cell lines | bioRxiv
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv

Summary of clinical trials using YM155 in cancer. | Download Scientific  Diagram
Summary of clinical trials using YM155 in cancer. | Download Scientific Diagram

YM155 inhibits formation and expansion of gastric cancer spheres. A.... |  Download Scientific Diagram
YM155 inhibits formation and expansion of gastric cancer spheres. A.... | Download Scientific Diagram

JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by  YM155 in Synovial Sarcoma | HTML
JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma | HTML

Testing of the survivin suppressant YM155 in a large panel of drug-resistant  neuroblastoma cell lines | bioRxiv
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv

Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium  Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports

Summary of clinical trials using YM155 in cancer. | Download Scientific  Diagram
Summary of clinical trials using YM155 in cancer. | Download Scientific Diagram

Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium  Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports

YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and  in vivo
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo

Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is  mediated by time-dependent inhibition of the NF-κB pathway | Scientific  Reports
Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway | Scientific Reports

YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and  survivin downregulation
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation

YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase  inhibitors through the mechanism of autophagy induction - ScienceDirect
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction - ScienceDirect

YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and  in vivo
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo

Survivin and YM155: How faithful is the liaison? - ScienceDirect
Survivin and YM155: How faithful is the liaison? - ScienceDirect

Summary of clinical trials using YM155 in cancer. | Download Scientific  Diagram
Summary of clinical trials using YM155 in cancer. | Download Scientific Diagram

YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and  survivin downregulation
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation

The over-expression of survivin enhances the chemotherapeutic efficacy of  YM155 in human hepatocellular carcinoma | Oncotarget
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma | Oncotarget

YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and  survivin downregulation
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation

Suppression of endogenous Survivin by YM155 occurs through a... | Download  Scientific Diagram
Suppression of endogenous Survivin by YM155 occurs through a... | Download Scientific Diagram

Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a  Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines

YM155, a survivin suppressant, triggers PARP-dependent cell death  (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in  mice | Oncotarget
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice | Oncotarget